Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic Cystitis
Clinical trial NCT04696666 · UNKNOWN
Trial details
- NCT number
- NCT04696666
- Sponsor
- LIDDE Therapeutics
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-15
- Primary completion
- 2021-05-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.